RecruitingNCT07456436
Data-Driven Strategies for Patient Engagement About Cancer Clinical Trials
Sponsor
University of Southern California
Enrollment
50 participants
Start Date
Nov 26, 2024
Study Type
OBSERVATIONAL
Conditions
Summary
This study assesses patient awareness and understanding of cancer clinical trials.
Eligibility
Min Age: 21 Years
Inclusion Criteria3
- Eligible patient participants will be:
- Black/African American, Asian/Asian American, White or Hispanic adults of any gender 21 years of age or older. Race/ethnicity will be self-reported
- Have been diagnosed any cancer type
Exclusion Criteria3
- Participants (patients) will be excluded if they:
- Are unable to give informed consent
- Are unable to speak English or Spanish
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
OTHERNon-Interventional Study
Non-interventional study
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07456436
Related Trials
Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted Treatment for HER2+ Solid Tumors (A ComboMATCH Treatment Trial)
NCT06126276187 locations
Temozolomide and Survivin Long Peptide Vaccine (SurVaxM) for the Treatment of Patients With Progressing Metastatic Neuroendocrine Carcinomas
NCT062020661 location
Acupressure for the Reduction of Anxiety in Patients Receiving Cancer-Directed Therapy
NCT067230411 location
Social Health, Activity Behaviors, and Quality of Life Among Young Adult Cancer Survivors
NCT072593042 locations
Investigating Memory and Physical Activity After Cancer Treatment in Survivors of Adolescent and Young Adult Cancers
NCT068808611 location